mutations provided The truth that, as described beneath, CLL therapy is based on the existence or absence of those mutations. The current consensus is usually that, in addition to clonal mutations, subclonal mutations by using a variant allelic frequency ranging from five to 10% (and therefore down below the brink of detection by standard molecular